Is pseudoexfoliation glaucoma a neurodegenerative disorder?
- PMID: 34785624
Is pseudoexfoliation glaucoma a neurodegenerative disorder?
Abstract
Pseudoexfoliation (PEX) is a systemic age-related progressive disorder with ocular manifestations. The earlier stage of the disease, pseudoexfoliation syndrome (PEXS) involves deposition of white fibrillar aggregates on anterior and posterior eye tissues. It is also the cause of most common form of secondary glaucoma known as pseudoexfoliation glaucoma (PEXG). Studies in the past decade highlight the role of many genetic and environmental factors as the underlying cause of PEX pathogenesis. Latest research findings by various researchers and us present the view of PEX as a type of neurodegenerative disorder. Epidemiological studies have shown association of PEX with different forms of neurodegenerative diseases like Alzheimer's, agerelated macular degeneration and open angle glaucoma. Also, sharing of common genetic risk factors, abnormal protein aggregation and most importantly, progressive degeneration of neurons with age are some of the identifiable features seen in both PEX and other neurodegenerative diseases. In this review, we have compared the pathological symptoms and factors involved in the disease manifestation of PEXG with various forms of neurodegenerative disorders and categorized PEXG as a progressive neurodegenerative disorder.
Similar articles
-
Current understanding of genetics and epigenetics in pseudoexfoliation syndrome and glaucoma.Mol Aspects Med. 2023 Dec;94:101214. doi: 10.1016/j.mam.2023.101214. Epub 2023 Sep 18. Mol Aspects Med. 2023. PMID: 37729850 Review.
-
Proteomics of pseudoexfoliation materials in the anterior eye segment.Adv Protein Chem Struct Biol. 2021;127:271-290. doi: 10.1016/bs.apcsb.2021.03.004. Epub 2021 Apr 26. Adv Protein Chem Struct Biol. 2021. PMID: 34340770 Review.
-
[New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].Ophthalmologe. 2012 Oct;109(10):944-51. doi: 10.1007/s00347-012-2531-1. Ophthalmologe. 2012. PMID: 23053330 Review. German.
-
Quantitative analysis of circulating levels of vimentin, clusterin and fibulin-5 in patients with pseudoexfoliation syndrome and glaucoma.Exp Eye Res. 2022 Nov;224:109236. doi: 10.1016/j.exer.2022.109236. Epub 2022 Aug 31. Exp Eye Res. 2022. PMID: 36055390
-
Association of LOXL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki eye study.Invest Ophthalmol Vis Sci. 2014 Jun 10;55(7):4238-43. doi: 10.1167/iovs.14-13991. Invest Ophthalmol Vis Sci. 2014. PMID: 24917141 Free PMC article.
Cited by
-
Olfactory Dysfunction and Glaucoma.Biomedicines. 2024 May 2;12(5):1002. doi: 10.3390/biomedicines12051002. Biomedicines. 2024. PMID: 38790964 Free PMC article. Review.
-
Twenty Novel MicroRNAs in the Aqueous Humor of Pseudoexfoliation Glaucoma Patients.Cells. 2023 Feb 24;12(5):737. doi: 10.3390/cells12050737. Cells. 2023. PMID: 36899874 Free PMC article.
-
Beyond the Dusty Fog: Local Eye Drop Therapy and Potentially New Treatment Alternatives in Pseudoexfoliative Glaucoma.Curr Med Chem. 2024;31(13):1608-1619. doi: 10.2174/0109298673255220231010073215. Curr Med Chem. 2024. PMID: 37855339 Review.
-
Exploring the Ocular Surface Microbiome and Tear Proteome in Glaucoma.Int J Mol Sci. 2024 Jun 6;25(11):6257. doi: 10.3390/ijms25116257. Int J Mol Sci. 2024. PMID: 38892444 Free PMC article.
-
Glaucoma, Pseudoexfoliation and Hearing Loss: A Systematic Literature Review.J Clin Med. 2024 Feb 28;13(5):1379. doi: 10.3390/jcm13051379. J Clin Med. 2024. PMID: 38592217 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous